Document:

Q2 2014 Exhibit 10.3

Exhibit 10.3

FOURTH AMENDMENT TO  
LOAN AND SECURITY AGREEMENT
THIS FOURTH AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into effective as of June 29, 2014, by and between OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined below) or otherwise party thereto from time to time including Oxford in its capacity as a Lender and SQUARE 1 BANK, a North Carolina banking corporation with an office located at 406 Blackwell Street, Suite 240, Durham, NC 27701 (“Bank” or “Square 1”) (each a “Lender” and collectively, the “Lenders”) and LIPOSCIENCE, INC., a Delaware corporation with offices located at 2500 Sumner Boulevard, Raleigh, NC 27616 (“Borrower”).
RECITALS
A.    Collateral Agent, Lenders and Borrower have entered into that certain Loan and Security Agreement dated as of December 20, 2012 (as amended, restated, supplemented or otherwise modified from time to time, including but without limitation by that certain First Amendment to Loan and Security Agreement dated as of June 11, 2013, that certain Second Amendment to Loan and Security Agreement dated as of October 31, 2013 and that certain Third Amendment to Loan and Security Agreement dated as of January 19, 2014, the “Loan Agreement”).
B.    Lenders have extended credit to Borrower for the purposes permitted in the Loan Agreement.
C.    Borrower has requested that Collateral Agent and Lenders (i) amend the financial covenants and (ii) make certain other revisions to the Loan Agreement as more fully set forth herein.
D.    Collateral Agent and Lenders have agreed to amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:
1.    Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.
2.    Amendments to Loan Agreement.
2.1    Section 6.10 (Financial Covenants).  Section 6.10(ii) of the Loan Agreement hereby is amended and restated in its entirety to read as follows:
“(ii)    Liquidity Ratio.  A Liquidity Ratio of at least 1.25 to 1.00.”
2.2    Section 13.1 (Definitions). The following definitions hereby are added to or amended and restated in their entirety in Section 13.1 of the Loan Agreement as follows:

1

“Ancillary Services” means corporate credit card services, Letters of Credit or other treasury management services requested by Borrower and approved by Bank under the Revolving Line.
“Ancillary Services Sublimit” is a sublimit for Ancillary Services under the Revolving Line not to exceed Three Hundred Fifty Thousand Dollars ($350,000.00) for corporate credit card services and for a Letter of Credit to support Borrower’s credit cards.
“Liquidity Ratio” means the ratio of (a) unrestricted cash, plus the amount of Advances available under the Revolving Line, to (b) all Indebtedness of Borrower to Collateral Agent and Lenders under the Term Loans, plus all Indebtedness of Borrower to Collateral Agent and Lenders under the Revolving Line (including the amounts outstanding under the Ancillary Services Sublimit).
2.3    Section 13.1 (Definitions). The following definition hereby is deleted in its entirety from Section 13.1 of the Loan Agreement:
“Revenue”.
2.4    Exhibit C to the Loan Agreement hereby is replaced by Exhibit C attached hereto.
2.5    Exhibit D to the Loan Agreement hereby is replaced by Exhibit D attached hereto.
3.    Limitation of Amendment.
3.1    The amendments set forth in Section 2 are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Collateral Agent or any Lender may now have or may have in the future under or in connection with any Loan Document.
3.2    This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.
4.    Representations and Warranties.  To induce Collateral Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Collateral Agent and Lenders as follows:
4.1    Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;
4.2    Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment;
4.3    The organizational documents of Borrower delivered to Collateral Agent and Lenders on June 10, 2013, or subsequent thereto, remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;
4.4    The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized;

2

4.5    The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;
4.6    The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made; and
4.7    This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.
5.    Counterparts.  This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.
6.    Effectiveness.  This Amendment shall be deemed effective upon the due execution and delivery to Collateral Agent and Lenders of (i) this Amendment by each party hereto and (ii) Borrower’s payment of all Lenders’ Expenses incurred through the date of this Amendment.
[Balance of Page Intentionally Left Blank]

3

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above,
	
		
	COLLATERAL AGENT AND LENDER:

	 
	 

	OXFORD FINANCE LLC

	 
	 

	By:
	/s/    Mark Davis

	Name:
	Mark Davis

	Title:
	Vice President - Finance, Secretary & Treasurer

	
		
	LENDER:

	 
	 

	SQUARE 1 BANK

	 
	 

	By:
	/s/    Michael Fulton

	Name:
	Michael Fulton

	Title:
	Assistant Vice President

	
		
	BORROWER:

	 
	 

	LIPOSCIENCE, INC.

	 
	 

	By:
	/s/    Lucy G. Martindale

	Name:
	Lucy G. Martindale

	Title:
	Chief Financial Officer

4

EXHIBIT C
Compliance Certificate
		
	TO:
	OXFORD FINANCE LLC, as Collateral Agent and Lender 
SQUARE 1 BANK, as Lender

		
	FROM:
	LIPOSCIENCE, INC.

The undersigned authorized officer (“Officer”) of LIPOSCIENCE, INC. (“Borrower”), hereby certifies that in accordance with the terms and conditions of the Loan and Security Agreement by and among Borrower, Collateral Agent, and the Lenders from time to time party thereto (the “Loan Agreement;” capitalized terms used but not otherwise defined herein shall have the meanings given them in the Loan Agreement),
(a)    Borrower is in complete compliance for the period ending _____________ with all required covenants except as noted below;
(b)    There are no Events of Default, except as noted below;
(c)    Except as noted below, all representations and warranties of Borrower stated in the Loan Documents are true and correct in all material respects on this date and for the period described in (a), above; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date.
(d)    Borrower, and each of Borrower’s Subsidiaries, has timely filed all required tax returns and reports, Borrower, and each of Borrower’s Subsidiaries, has timely paid all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower, or Subsidiary, except as otherwise permitted pursuant to the terms of Section 5.8 of the Loan Agreement;
(e)    No Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Collateral Agent and the Lenders.
Attached are the required documents, if any, supporting our certification(s).  The Officer, on behalf of Borrower, further certifies that the attached financial statements are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one period to the next except as explained in an accompanying letter or footnotes and except, in the case of unaudited financial statements, for the absence of footnotes and subject to year-end audit adjustments as to the interim financial statements.
Please indicate compliance status since the last Compliance Certificate by circling Yes, No, or N/A under “Complies” column.

	
					
	 
	Reporting Covenant
	Requirement
	Actual
	Complies

	1)
	Financial statements
	Monthly within 30 days
	 
	Yes   No   N/A

	2)
	Annual (CPA Audited) statements
	Within 180 days after FYE
	 
	Yes   No   N/A

	3)
	Annual Financial
Projections/Budget (prepared on a monthly basis)
	Annually (within 10 days of FYE), and when revised
	 
	Yes   No   N/A

	4)
	Borrowing Base Certificate; A/R & A/P agings
	Monthly within 30 days
	 
	Yes   No   N/A

	5)
	8-K, 10-K and 10-Q Filings
	If applicable, within 5 days of filing
	 
	Yes   No   N/A

	6)
	Compliance Certificate
	Monthly within 30 days
	 
	Yes   No   N/A

	7)
	IP Report
	When required
	 
	Yes   No   N/A

	8)
	Vantera Machines Report
	At close; annually, each March 31
	 
	Yes   No   N/A

	9)
	Total amount of Borrower’s cash and cash equivalents at the last day of the measurement period
	 
	$__________
	Yes   No   N/A

	10)
	Total amount of Borrower’s Subsidiaries’ cash and cash equivalents at the last day of the measurement period
	 
	$__________
	Yes   No   N/A

Deposit and Securities Accounts 
(Please list all accounts; attach separate sheet if additional space needed)
	
										
	 
	Institution Name
	Account Number
	New Account?
	Account Control Agreement in place?

	1)
	 
	 
	Yes
	No
	Yes
	No

	2)
	 
	 
	Yes
	No
	Yes
	No

	3)
	 
	 
	Yes
	No
	Yes
	No

	4)
	 
	 
	Yes
	No
	Yes
	No

Financial Covenants
	
							
	 
	Covenant
	Requirement
	Actual
	Compliance

	1)
	Liquidity Ratio
	1.25:1.00
	________ to 1.00
	Yes
	No

	2)
	Minimum Quick Ratio
	At least 1.25:1.00 (from the Effective Date thru 2/28/13)*
	________ to 1.00
	Yes
	No

*    1.10 to 1.00; 3/1/13 thru 6/30/13
1.00 to 1.00; 7/1/13 and thereafter

Other Matters
	
				
	1)
	Have there been any changes in management since the last Compliance Certificate?
	Yes
	No

	2)
	Have there been any transfers/sales/disposals/retirement of Collateral or IP prohibited by the Loan Agreement?
	Yes
	No

	3)
	Have there been any new or pending claims or causes of action against Borrower that involve more than Two Hundred Fifty Thousand Dollars ($250,000.00)?
	Yes
	No

	4)
	Have there been any amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries? If yes, provide copies of any such amendments or changes with this Compliance Certificate.
	Yes
	No

Exceptions
Please explain any exceptions with respect to the certification above: (If no exceptions exist, state “No exceptions.” Attach separate sheet if additional space needed.)
	
		
	LIPOSCIENCE, INC.

	 
	 

	By:
	 

	Name:
	 

	Title:
	 

	 
	 

	Date:
	 

	
						
	LENDER USE ONLY:
	 
	 
	 

	 
	 
	 
	 
	 
	 

	Received by:
	 
	 
	 
	Date:
	 

	Verified by:
	 
	 
	 
	Date:
	 

	 
	 
	 
	 
	 
	 

	Compliance Status:
	Yes
	 
	 
	No

EXHIBIT D
Borrowing Base Certificate

[provided by Bank]ex10-1.htm

Exhibit 10.1

 

	
Hudson Bay Master Fund, Ltd.

	
c/o Hudson Bay Capital Management LP

	
777 Third Ave., 30th Floor

	
New York, NY 10017

 

	
August 8, 2014

 

ELECTRONIC MAIL

	
Fuse Science, Inc.

6135 NW 167th Street, #E21

Miami Lakes, Florida 33015

 

Gentlemen:

 

In consideration of the premises and the agreements in this letter agreement (the "Letter Agreement") and for other consideration, the receipt and sufficiency of which are hereby acknowledged, Fuse Science, Inc., a Nevada corporation with offices located at 6135 NW 167th Street, #E21, Miami Lakes, Florida 33015 (the "Company") hereby agrees to offer and sell to the undersigned and the undersigned hereby agrees to purchase from the Company (i) senior secured convertible notes (the "August 2014 Notes"), in the form attached as Exhibit A to that certain Securities Purchase Agreement dated as of January 3, 2014 by and among the Company and the investors listed on the signature pages attached thereto, in the aggregate principal amount of $20,000, which Notes shall be convertible into shares of the Company's common stock, $0.001 par value per share (the "Common Stock") and (ii) warrants (the "August 2014 Warrants ") to purchase [6,250,000] shares of Common Stock in the form attached as Exhibit B to the SPA. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the SPA.

 

In the interest of expediency, (i) the undersigned incorporates by reference the representations and warranties set forth in Section 2 of the SPA and is making such representations and warranties, mutatis mutandis, to the Company as of the date hereof and as of the date of the consummation of the transactions contemplated hereby (the "August 2014 Closing"), which shall be August 8, 2014 (the "August 2014 Closing Date") (ii) the Company by countersigning this Letter Agreement incorporates by reference the representations and warranties set forth in Section 3 of the SPA and is making such representations and warranties, mutatis mutandis, to the undersigned as of the date hereof and as of the August 2014 Closing Date and (iii) the undersigned and the Company hereby agree that the other provisions of the SPA, including without limitations, the closing conditions set forth in Sections 6 and 7 of the SPA, shall be incorporated by reference into this Letter Agreement, mutatis mutandis, and that for purposes of such provisions (A) the August 2014 Notes shall be deemed "Additional Notes", (B) the August 2014 Warrants shall be deemed "Additional Warrants", (C) the August 2014 Closing shall be deemed an "Additional Closing" and (D) the August 2014 Closing Date shall be deemed an "Additional Closing Date".

 

The Company hereby agrees and acknowledges that the transactions contemplated by this Letter Agreement does not constitute material, nonpublic information of the Company and that the undersigned is not subject to any confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the undersigned or any of its affiliates, on the other hand. The Company understands and confirms that the undersigned and its affiliates will rely on the foregoing representations in effecting transactions in securities of the Company.

  

-1-

  

Fuse Science, Inc.

August 8, 2014

This Letter Agreement may be executed in any number of counterparts, which together shall constitute one and the same agreement.  In the event that any provision of this Letter Agreement is found to be void or invalid, then such provision shall be deemed to be severable from the remaining provisions of this Letter Agreement, and it shall not affect the validity of the remaining provisions, which provisions shall be given full effect as if the void or invalid provision had not been included herein.  The terms and provisions of this Letter Agreement shall inure to the benefit of and be binding upon the heirs, successors and assigns of the parties.  This Letter Agreement shall be governed by, and construed in accordance with, the laws of the State of New York (without giving effect to the conflict of laws principles thereof).  The courts of the State of New York shall have exclusive jurisdiction to resolve any and all disputes that may arise under this Letter Agreement.  Any amendments or modifications hereto must be executed in writing by all parties. Each party hereto shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this letter agreement.

 

 

	 	Very truly yours,
	 	 
	 	
HUDSON BAY MASTER FUND LTD.

	 	
By: HUDSON BAY CAPITAL MANAGEMENT, L.P., its Investment Manager

	 	  
	 	  
	 	
By:  /s/ George Antonopoulos

Name:  George Antonopoulos

Title:  Authorized Signatory

 

Acknowledged and Agreed as of this 8th day of August, 2014

 

	
FUSE SCIENCE, INC.

 

 

By:  /s/ Brian Tuffin

Name:  Brian Tuffin

Title:  CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]